Castle Biosciences, Inc. (CSTL)

NASDAQ: CSTL · Real-Time Price · USD

32.76

+0.36 (1.11%)

At close: Feb 6, 2026, 4:00 PM EST

33.40

+0.64 (1.95%)

After-hours: Feb 6, 2026, 7:49 PM EST

Castle Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	956	746	581	620	1,103	1,622
Market Cap Growth	28.80%	28.53%	-6.38%	-43.76%	-32.00%	176.41%
Enterprise Value	706	493	366	368	740	1,461
Last Close Price	32.75	26.65	21.58	23.54	42.87	67.15
PE Ratio	-	40.91	-	-	-	-
PS Ratio	2.73	2.25	2.64	4.53	11.72	25.89
PB Ratio	2.04	1.64	1.48	1.55	2.68	3.90
P/TBV Ratio	2.62	2.13	2.12	2.27	3.42	3.90
P/FCF Ratio	37.67	20.43	-	-	-	317.18
P/OCF Ratio	15.47	11.51	-	-	-	164.43
EV/Sales Ratio	2.05	1.49	1.66	2.69	7.86	23.33
EV/EBITDA Ratio	90.12	20.00	-	-	-	-
EV/EBIT Ratio	-	56.90	-	-	-	-
EV/FCF Ratio	27.80	13.50	-	-	-	285.78
Debt / Equity Ratio	0.08	0.06	0.04	0.03	0.02	-
Debt / EBITDA Ratio	3.40	0.96	-	-	-	-
Debt / FCF Ratio	1.46	0.72	-	-	-	-
Asset Turnover	0.64	0.68	0.49	0.30	0.21	0.22
Inventory Turnover	9.05	7.49	7.55	10.67	7.47	5.61
Quick Ratio	6.12	6.97	5.90	7.81	13.94	20.24
Current Ratio	6.47	7.29	6.20	8.09	14.22	20.58
Return on Equity (ROE)	-2.70%	4.31%	-14.54%	-16.56%	-7.56%	-4.11%
Return on Assets (ROA)	-1.72%	1.10%	-9.43%	-12.52%	-5.56%	-1.88%
Return on Invested Capital (ROIC)	-6.84%	4.16%	-42.80%	-74.56%	-76.66%	-97.79%
Return on Capital Employed (ROCE)	-2.90%	1.80%	-16.80%	-22.20%	-9.20%	-2.00%
Earnings Yield	-1.28%	2.44%	-9.89%	-10.82%	-2.84%	-0.63%
FCF Yield	2.65%	4.90%	-3.31%	-7.62%	-2.04%	0.32%
Buyback Yield / Dilution	-1.04%	-9.15%	-2.87%	-3.65%	-32.80%	-118.63%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q